With all the talk about private equity $$$ in the news would not SUPG be a very attractive takeover canidate? If MGI or another Phama is not going to step up to buy out Supergen then maybee someone else will. Seems like a no brainer.
Private equity would need a buyer arranged to take over the development drugs and unless they can prearrange this, I see this as a long shot at best. Anyone, that wanted the development stage drugs, would also want the developed drug. I also see SUPG putting up a fight on any private equity deal. They are high on MP-470/529. I have stated this point before, if 470 demonstrates benefits to first in line chemo/anti-cancer agents, we could see approval for this drug in record time.